Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.

Tan HH, Hoppe J, Heard K.

Am J Emerg Med. 2009 Jun;27(5):607-16. doi: 10.1016/j.ajem.2008.04.020. Review.

2.

Antipsychotic poisoning in young children: a systematic review.

Isbister GK, Balit CR, Kilham HA.

Drug Saf. 2005;28(11):1029-44. Review.

PMID:
16231955
3.

Olanzapine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006654. doi: 10.1002/14651858.CD006654.pub2. Review.

4.

Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.

Jing Y, Kim E, You M, Pikalov A, Tran QV.

J Med Econ. 2009 Jun;12(2):104-13. doi: 10.3111/13696990903044092.

PMID:
19527195
5.

Risperidone versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006626. doi: 10.1002/14651858.CD006626.pub2. Review.

6.
7.

Atypical antipsychotics for psychosis in adolescents.

Kumar A, Datta SS, Wright SD, Furtado VA, Russell PS.

Cochrane Database Syst Rev. 2013 Oct 15;(10):CD009582. doi: 10.1002/14651858.CD009582.pub2. Review.

PMID:
24129841
8.

Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.

Olfson M, Gerhard T, Huang C, Lieberman JA, Bobo WV, Crystal S.

Schizophr Bull. 2012 Jun;38(4):845-53. doi: 10.1093/schbul/sbq172. Epub 2011 Feb 9.

9.

Quetiapine versus other atypical antipsychotics for schizophrenia.

Asmal L, Flegar SJ, Wang J, Rummel-Kluge C, Komossa K, Leucht S.

Cochrane Database Syst Rev. 2013 Nov 18;(11):CD006625. doi: 10.1002/14651858.CD006625.pub3. Review.

PMID:
24249315
10.

A case series of ziprasidone overdoses.

Bryant SM, Zilberstein J, Cumpston KL, Magdziarz DD, Costerisan DD.

Vet Hum Toxicol. 2003 Mar;45(2):81-2.

PMID:
12678292
11.
12.

Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.

Stauffer V, Ascher-Svanum H, Liu L, Ball T, Conley R.

BMC Psychiatry. 2009 Mar 31;9:13. doi: 10.1186/1471-244X-9-13.

13.

Comparison of pediatric atypical antipsychotic exposures reported to U.S. poison centers.

Stassinos G, Klein-Schwartz W.

Clin Toxicol (Phila). 2017 Jan;55(1):40-45. doi: 10.1080/15563650.2016.1233342. Epub 2016 Sep 20.

PMID:
27644404
14.

A model of anticholinergic activity of atypical antipsychotic medications.

Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Kirshner MA, Bies RR, Kapur S, Gharabawi G.

Schizophr Res. 2006 Dec;88(1-3):63-72. Epub 2006 Aug 22.

PMID:
16928430
15.

Quetiapine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, Srisurapanont M, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006625. doi: 10.1002/14651858.CD006625.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD006625.

16.

Overdoses and ingestions of second-generation antipsychotics in children and adolescents.

Antia SX, Sholevar EH, Baron DA.

J Child Adolesc Psychopharmacol. 2005 Dec;15(6):970-85.

PMID:
16379518
17.

Atypical antipsychotics in the management of delirium: a review of the empirical literature.

Boettger S, Breitbart W.

Palliat Support Care. 2005 Sep;3(3):227-37. Review.

PMID:
16594462
18.

Aripiprazole (abilify) overdose in a child.

Seifert SA, Schwartz MD, Thomas JD.

Clin Toxicol (Phila). 2005;43(3):193-5.

PMID:
15902794
19.

Pediatric quetiapine overdose: a case report and literature review.

Catalano G, Catalano MC, Agustines RE, Dolan EM, Paperwalla KN.

J Child Adolesc Psychopharmacol. 2002 Winter;12(4):355-61.

PMID:
12625997
20.

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, Kissling W, Davis JM, Leucht S.

Schizophr Res. 2010 Nov;123(2-3):225-33. doi: 10.1016/j.schres.2010.07.012. Epub 2010 Aug 7. Review.

Supplemental Content

Support Center